This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Ford Beats, GM Stalls, Eli Lilly Reports & Jim Cramer's Bank Pick

On a massive earnings day, Ford topped estimates on the earnings side, but disappointed on its revenue.

Facebook Blows Away Earnings Estimates: Chart of the Day

Facebook's Wednesday earnings report blew away predictions, with monthly average users and daily average users each growing double digits year over year.

Apple, Facebook Beats Good Signs for Earnings Reports

Alan Knuckman discusses big tech beats, from companies including Apple and Facebook, and what it means for earnings going forward.

Gilead Sciences Beats Street and Sees Sovaldi Sales Double

Gilead Sciences shares rose sharply in after-hours trading on Wednesday after the company reported second quarter results which surpassed analyst forecasts.

GM Recalls More Vehicles as U.S. Markets Close Mixed

U.S. markets ended Wednesday's session mixed but one bright spot was the S&P 500 which closed at a new record.

Real Money Previews

Cramer: Every Which Way But Short

In theory, there should be plenty of shorting opportunities.

Melvin: Wait for Quality and Price to Meet

It is worth the patience and discipline required.

Cramer: It's the Tone That Makes the Music

Look for confidence during earnings calls.

Mad Money Recap

'Mad Money' Lightning Round: Buy, Buy, Buy Hexcel

Cramer prefers EOG Resources over Magnum Hunter and Dow Chemical over PolyOne.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

Hedge Funds Hate These 5 Stocks -- Should You?

Looking at which stocks hedge funds are selling can tell even more than studying what they're buying.

3 Stocks Under $10 to Trade for Breakouts

These under-$10 stocks are within range of triggering breakout trades.

4 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

MainStreet

Pro Golfer Rickie Fowler on Getting Americans Back Into the Sport

Professional golfer Rickie Fowler reveals the reasons why golf has been on the decline in America and how he's trying to lure players back into the game.

Young Americans Prefer Bank Investments, Not Stock Market

That's a problem, because younger Americans aren't going to meet their giant retirement savings burden with low-yielding cash investments.

LendingTree CEO: New Credit Platform Scoring Big With Borrowers

LendingTree is expanding beyond its legacy mortgage comparison business with a personalized credit monitoring platform, said the company's CEO Douglas Lebda.

3 Tips for the Long-Term Unemployed

Yes, it's a tough slog looking for work over a long period. But keep cool, explore all options and don't give up -- and try these tips.

5 Great Places to Retire Without a Car

Your car is sucking the life out of your retirement savings and anchoring you to an unsustainable future. Ditch your car and worries for the good life.

Biotech

Gilead Sovaldi $3.5 Billion: The Most Important Number in Biotech Earnings Season

In its first two quarters on the market, Sovaldi, a pill used to treat hepatitis C, has delivered $5.8 billion in revenue to Gilead. Remarkable.

Puma Shares Soar When Wall Street Misplays Expectation Game

Puma is why so many investors love to speculate on biotech stocks. A contrarian trade against a heavily expected outcome can return a fortune.

Inovio Declares Spin-Laden Victory With DNA Vaccine

Inovio's analysis of the VGX-3100 study omits an unknown number of patients, calling the results into question.

Beyond Wall St.

Deal News

Why Covidien Stock Is Still Undervalued Despite the Medtronic Deal

As long as Covidien stock remains under $97 per share, it's a buy.

Evercore, Cullen Frost and South State Remain Fabulous Financials

Boutique investment bank Evercore Partners is benefiting from the surge in M&A, as well as a stricter regulatory environment for financial companies.

Algonquin Power Goes Activist on Its Target Gas Natural

When approached about whether it had spoken with potential suitors, Gas Natural responded with a flat denial, claiming its board had not talked to anyone about a possible sale.

TheStreetTV
Spin Space

Jim Cramer

Cramer: Every Which Way But Short

In theory, there should be plenty of shorting opportunities.

Herb Greenberg

Greenberg: Ackman and Herbalife -- The Day After

Bill Ackman's presentation failed to impress investors, but it probably should have, as Ackman raised several important points.

Stephanie Link

Link: Waddell & Reed Offers Growth at a Nice Price

This asset manager's stock pullback looks like an opportunity.

Chris Ciaccia

Facebook Q2 Earnings Live Blog Recap

Facebook earnings blew past Wall Street estimates, as the social network continues to be a mobile advertising giant.

Adam Feuerstein

Gilead Sovaldi $3.5 Billion: The Most Important Number in Biotech Earnings Season

In its first two quarters on the market, Sovaldi, a pill used to treat hepatitis C, has delivered $5.8 billion in revenue to Gilead. Remarkable.

Laurie Kulikowski

American Apparel Should Hire One of These 6 Executives to Replace Dov Charney

As American Apparel gets ready for a second life, a life unlikely to include embattled former CEO Dov Charney, who else would be a good fit to run the retailer?

Dan Freed

Barclays Charged With Fraud Over 'Dark Pool'

Barclays Capital committed fraud tied to a private, internal stock trading platform known as a 'dark pool,' according to charges filed Wednesday by New York Attorney General Eric S...

Rocco Pendola

Was Apple's Demolition of BlackBerry 'Click Bait' or Did It Actually Happen?

Looking back at BlackBerry's 2011 collapse should prompt investors to at least look twice and think before they blow off predictions of Microsoft's collapse at the hands of Apple.

Ted Reed

Delta Says Not to Fear International Unit Revenue Declines

Delta spooked investors when it reported some international traffic weakness during June but it reassured investors on Wednesday.

Leon Lazaroff

Comcast Is Now the Center Which the World Revolves Around

Comcast adds more broadband subscribers than forecast in its second quarter, possibly weakening its argument that it needs to acquire Time Warner Cable to defend its business.

Submit an article to us!
DOW 17,086.63 -26.91 -0.16%
S&P 500 1,987.01 +3.48 0.18%
NASDAQ 4,473.6970 +17.6810 0.40%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs